Firazyr

Takeda Patient Support Co-Pay Assistance Program Patient Guide: How to Get Firazyr (icatibant) at Low or No Cost

Firazyr (icatibant) is a prescription medication used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years and older. The Takeda Patient Support Co-Pay Assistance Program helps eligible commercially insured patients cover up to 100% of their out-of-pocket co-pay costs for Firazyr, potentially reducing costs to as little as $5 per dose or even $0, depending on eligibility[2][4][5].

About Firazyr and Hereditary Angioedema (HAE)

Firazyr (icatibant injection) is a subcutaneous (under-the-skin) injection that works quickly to treat sudden HAE attacks. HAE is a rare genetic condition causing episodes of swelling in various parts of the body, such as the face, hands, feet, genitals, or throat, which can be painful and life-threatening if they affect the airway. Firazyr blocks a protein called bradykinin that causes this swelling, providing relief usually within 2 hours after injection[3][4].

Patients self-administer Firazyr at the first sign of an attack, making it an essential tool for managing this unpredictable condition. It's pre-filled and ready-to-use, stored at room temperature for convenience. Always follow your doctor's instructions for use, and contact emergency services if swelling affects your airway.

Who Qualifies for the Program?

This program is designed for commercially insured patients aged 18 and older prescribed Firazyr. Key eligibility points include:

• Commercial insurance (private employer or marketplace plans)—not Medicare, Medicaid, or government insurance.
• No income requirements or financial eligibility thresholds; eligibility depends on your insurance type, plan, and state of residence[4].
• Covers up to 100% of co-pays, up to program maximums (state restrictions may apply)[2][4].

Income Eligibility Breakdown

Since there are no specific income limits, everyone with qualifying commercial insurance may apply. Here's a simple overview:

This makes the program accessible without proving financial hardship, unlike many assistance programs[4][5]. Your OnePath Patient Support Manager can confirm eligibility based on your specific insurance[4].

Insurance Requirements

Commercial insurance is required. The program does not cover:

• Medicare Part D, Medicaid, TRICARE, VA, or other federal programs.
• Uninsured or underinsured patients (see alternatives below).

If your plan changes or you have questions, contact Takeda Patient Support. They help navigate prior authorizations and benefits verification[1][5][10].

Step-by-Step Application Process

Applying is straightforward with multiple application methods:

1. Visit the Takeda Patient Support website: Go to takedapatientsupport.com and select Firazyr support. Download the co-pay card or enroll online[1][3][7].

2. Call OnePath Support: Contact your OnePath Patient Support Manager (PSM) at the number on your prescription or via the website. They'll guide enrollment[4].

3. Work with your doctor/pharmacy: Provide proof of commercial insurance and a valid Firazyr prescription. Your healthcare provider (HCP) can initiate via the HCP portal[3][9].

4. Required Documents:

   • Proof of commercial insurance (insurance card).
   • Prescription for Firazyr[program data].

5. Activate co-pay card: Once approved, use the digital or physical card at your specialty pharmacy or site of care. Assistance applies at checkout[2][5].

Takeda specialists handle paperwork, insurance verification, and even self-injection training[5][10].

Timeline and Delivery

• Processing time: Often fast—many commercial plans approve quickly. Exact timelines vary; your PSM provides updates[10].
• Delivery: Via specialty pharmacy (e.g., QuickRx) or site-of-care administration. Expect temperature-controlled home delivery with injection support[5][10].

Refills process automatically through your pharmacy; notify your PSM of any insurance changes.

Alternatives if Denied or Ineligible

If denied (e.g., non-commercial insurance):

• Medicare/Medicaid: Independent foundations offer grants—QuickRx connects you[10].
• Uninsured/underinsured: Takeda's Help at Hand program may provide free or low-cost Firazyr to eligible patients (varies by product)[5].
• Biosimilar alternative: Teva's icatibant injection, a lower-cost option with similar efficacy for HAE attacks[program data].

Discuss with your doctor; OnePath supports only Takeda Firazyr but can guide transitions[4].

Important Disclaimer

This guide is for informational purposes only and based on program details as of available data. Eligibility, benefits, and terms can change. Always verify with Takeda Patient Support (takedapatientsupport.com), your OnePath PSM, doctor, or pharmacist. Not a substitute for medical advice. Program may have state restrictions, maximums, and expiration. Takeda reserves rights to modify/amend/terminate[2][4]. Consult takedapatientsupport.com for latest terms. (Word count: 942)